Teladoc faces pressures following post-pandemic decline
By Erin Brodwin
Published on April 1, 2026.
An activist investor, Pineal Capital Management, has called for sweeping changes to the company's operations, suggesting that it should allow for a $200 million share repurchase program. The company's financial situation has been described as "under-levered" by the public. The investor is urging the company to cut costs and possibly break up.
Related Articles
San Francisco supervisor’s absence for mental health questioned after city attorney threatened removal from office
San Francisco Supervisor Jackie Fielder's mental health is under scrutiny due to a leaked legal memo, potentially leading to her removal from office.
CDC: U.S. tuberculosis cases hit highest level in more than a decade
Tuberculosis cases in the United States have reached their highest in nearly a decade, attributed largely to international travel, but early treatment and prevention are crucial.
FDA’s Makary touts ‘healing’ following DOGE cuts
FDA Commissioner Marty Makary credits his agency’s recent restructuring with a higher approval rate, shorter review times, and an embrace of artificial intelligence tools.